January is just around the corner, and before we know it, our CEO, Jeanne Hecht will be heading to San Francisco for the highly anticipated JPM Healthcare & Investor Conference! Send her a message if you'd like to catch up that week at ceo@lexitas.com. #JPM2025 #ClinicalResearch #Lexitas
Lexitas Pharma Services
Research Services
Durham, North Carolina 14,010 followers
More than a CRO: Your Partner for Unmatched Expertise and Precision in Ophthalmology Research
About us
Lexitas is a clinical research organization dedicated exclusively to ophthalmology since 2011. With unmatched expertise and precision in ophthalmic research, we deliver tailored approaches, rigorous quality standards, and unwavering commitment to operational success. Our dedicated team of ophthalmic experts guides each study with deep scientific and clinical experience, offering customized solutions to meet your needs at every stage of development. We have extensive experience in posterior and anterior segments, as well as rare diseases. Service Offerings: -Regulatory strategy -Study design and protocol development -Endpoint evaluation and selection -Site selection, management and training -Clinical project management and monitoring -Medical monitoring -Data management & Biostatistics -Reading center -Medical Affairs & commercialization strategies
- Website
-
http://www.lexitas.com/
External link for Lexitas Pharma Services
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- Durham, North Carolina
- Type
- Privately Held
- Founded
- 2011
- Specialties
- CRO, Pharmaceutical Research Services, Ophthalmology, Medical Device Research Services, and Clinical Trial Services
Locations
-
Primary
Get directions
5425 Page Rd
Suite 410
Durham, North Carolina 27703, US
Employees at Lexitas Pharma Services
Updates
-
In a recent article with Optometry Advisor, Andrew D. Pucker, OD, PhD, details the mechanism of action behind various myopia control spectacles and their potential for revolutionizing myopia treatment strategies. Visit their website to read the full review: https://hubs.li/Q030frm30
-
-
Continuing our Employee Feature Series, it's time to showcase one of our many awesome Medical Writers, Ben Ashberg! Ben joined Lexitas' Regulatory & Medical Writing team almost four years ago and plays a crucial role in delivering important study documents to our customers. Thank you for all you do for our sponsors, Ben! #EmployeeSpotlight #Lexitas #clinicalresearch #ophthalmology
-
Yesterday was the final day of our #12DaysofLexitas. We closed out the celebration with a holiday trivia night! #DecemberAtLexitas #Lexitas
-
-
Check out this recent article from Andrew Pucker and others on contact lens comfort. ⬇️
Executive Director of Clinical and Medical Science at Lexitas Pharma Services, Inc.
It’s well known that toric contact lens wearers struggle more with discomfort than spherical contact lens wears, yet there was limited information on real-time comfort in this group, so we decided to take a look. We overall found that while contact lens comfort does decrease in toric contact lens wearers across the day, comfort was still typically good in normal contact lens wearers and that comfort at any given time of day throughout a wear month is stable in a modern monthly contact lens. Come learn more here!
-
Thank you to Joseph Mancini from adMare BioInnovations for the kind words! "I am genuinely impressed by the Lexitas team's dedication and the guidance they provide. We went from a study concept to a strong protocol synopsis in just 4 weeks. Andrew D. Pucker, Executive Director of Medical and Clinical Sciences, provided expert feedback, and the medical writing team facilitated fruitful discussions and then implemented our decisions with expediency and accuracy. It's been a pleasure working with Lexitas, and I can confidently recommend them to my colleagues in the ophthalmology space." We are grateful for your trust and recommendation! #Lexitas #CRO #ophthalmology
-
-
🚨 New Episode Alert 🚨 In the latest episode of Inside Look, Andrew D. Pucker, OD, PhD, and Yesha Raval discuss enrollment rates in clinical trials. This topic was inspired by our recent paper "Running the numbers on enrollment rates in clinical trials in the US." In this episode, Andrew and Yesha discuss all things related to enrollment numbers, including how Global Data was used for this paper, how valuable site partnerships are to a successful trial, and how to maximize your partnership with your CRO. Watch the full episode now: https://hubs.li/Q02_r1pp0 #Lexitas #InsideLook #ClinicalResearch #Ophthalmology
-
-
Yesterday, our NC-based team members, along with a few out-of-towners, came together to celebrate the holidays at The Baxter Arcade in Chapel Hill, NC! #12DaysofLexitas #December #HappyHolidays Seemore Clearly
-
-
-
-
-
+4
-
-
Lexitas Pharma Services reposted this
How to Overcome Ocular Risks in Obesity Clinical Trials Anti-obesity medications have been linked to serious eye conditions like NAION, posing challenges to patient safety and trial success. In this one-pager, 20/20 Onsite and Lexitas Pharma Services outline how mobile ocular imaging solutions can help monitor eye health, safeguard participants, and streamline obesity trials. Download the guide to learn how to implement effective ocular monitoring and keep your study on track: https://hubs.ly/Q02-WPdZ0 #ClinicalTrials #OcularHealth #ObesityResearch
-
-
To launch our employee spotlight series, we had a chat with Project Manager, Lindsay Grier, about her journey in the ophthalmic field and what sparked her passion for this career. When we asked Lindsay what she loves most about working at Lexitas, she shared, "Lexitas gives me the opportunity to collaborate with an amazing team, clients, and partners to ensure clinical trials run smoothly. I feel appreciated by the team, and I appreciate everything I've learned from them in return." Thank you, Lindsay, for all you do for our customers and partners! #Lexitas #clinicalresearch #employeespotlight
-